HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition.
Ontology highlight
ABSTRACT: Epithelial-to-mesenchymal transition (EMT) is an embryonic program used by cancer cells to acquire invasive capabilities becoming metastatic. ΔRon, a constitutively active isoform of the Ron tyrosine kinase receptor, arises from skipping of Ron exon 11 and provided the first example of an alternative splicing variant causatively linked to the activation of tumor EMT. Splicing of exon 11 is controlled by two adjacent regulatory elements, a silencer and an enhancer of splicing located in exon 12. The alternative splicing factor and oncoprotein SRSF1 directly binds to the enhancer, induces the production of ΔRon and activates EMT leading to cell locomotion. Interestingly, we now find an important role for hnRNP A1 in controlling the activity of the Ron silencer. HnRNP A1 is able to antagonize
SUBMITTER: Bonomi S
PROVIDER: S-EPMC3794575 | biostudies-literature | 2013 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA